Mensifem

Cimicifuga racemosa, the active ingredient in Mensifem, is a herbal presented as a dry extract for oral use. It treats menopausal symptoms such as hot flashes and night sweats in women.

GNH USA supplies Mensifem as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mensifem, a black cohosh dry extract, is used in the management of menopausal symptomatology.

- Menopausal symptoms: alleviates hot flashes, night sweats and related discomfort. - Hot flashes: reduces frequency and intensity of vasomotor episodes. - Night sweats: helps decrease the number and severity of nocturnal sweating episodes.

Adverse reactions reported with black cohosh extracts are generally mild, but clinicians should remain vigilant.

Common Side Effects: - Gastrointestinal upset: mild nausea or stomach discomfort. - Headache: occasional transient headache. - Dizziness: brief episodes of light‑headedness. - Skin rash: mild erythema or itching. - Fatigue: temporary tiredness. - Mild insomnia: occasional difficulty sleeping.

Serious or Rare Side Effects: - Liver injury: signs of hepatitis or elevated liver enzymes. - Severe allergic reaction: anaphylaxis or angioedema. - Blood pressure changes: sudden hypertension or hypotension. - Thromboembolic events: rare clot formation. - Severe skin reactions: Stevens‑Johnson syndrome. - Acute pancreatitis: rare gastrointestinal emergency.

When considering Mensifem, healthcare professionals should assess individual risk factors and follow standard safety practices.

- Pregnancy: safety not established; avoid use during pregnancy. - Breastfeeding: insufficient data; use with caution. - Liver function: evaluate hepatic status before initiating therapy. - Concomitant hormone therapy: monitor for additive estrogenic effects. - Drug interactions: review all concurrent medications. - Store at ambient temperature: keep in original packaging, protect from moisture and light.

Potential interactions with other agents should be reviewed prior to prescribing Mensifem.

Major Interactions (Avoid): - Hormone replacement therapy: may increase estrogenic activity. - Anticoagulants: possible heightened bleeding risk.

Moderate Interactions (Monitor Closely): - Selective serotonin reuptake inhibitors: potential serotonergic synergy. - Cytochrome P450 substrates: black cohosh may alter metabolism of certain drugs. - Other estrogenic herbs or supplements: monitor for additive effects.